Specifically, the study aimed to evaluate whether boric acid treatment in U87 glioblastoma cells could serve as a potential therapeutic strategy for glioblastoma by targeting the SOX10/GPx4/ACSL4 signalling axis. This evidence concerns the gene ACSL4 and glioblastoma.